TransMedics (TMDX) Cash from Investing Activities Growth (3y) (2021 - 2026)
TransMedics (TMDX) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -17.67% |
| 10 | TransMedics | 3.15 Bn | 2.67 Bn | 113.20 Mn | -72.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -72.57% |
| Mar 31, 2026 | -240.69% |
| Dec 31, 2025 | -77.72% |
| Sep 30, 2025 | -32.15% |
| Jun 30, 2025 | -34.11% |
| Mar 31, 2025 | -65.97% |
| Dec 31, 2024 | -49.80% |
| Sep 30, 2024 | -113.30% |
| Jun 30, 2024 | -102.04% |
| Mar 31, 2024 | -89.12% |
| Dec 31, 2023 | -84.01% |
| Sep 30, 2023 | -85.50% |
| Jun 30, 2023 | 67.64% |
| Mar 31, 2023 | -27.50% |
| Dec 31, 2022 | -33.43% |
| Sep 30, 2022 | 49.16% |
| Jun 30, 2022 | 34.78% |
| Mar 31, 2022 | 1,419.26% |
| Dec 31, 2021 | 324.63% |
| Sep 30, 2021 | 130.53% |